Immunogenicity of the BNT162b2 mRNA Covid-19 vaccine in elderly people over 85 years of age in Greece: the GREVAXIMO study
BNT162b2 mRNA新冠疫苗在希腊85岁以上老年人群中的免疫原性：GREVAXIMO研究
期刊:Aging Clinical and Experimental Research
影响因子:3.4
doi:10.1007/s40520-021-01997-7
Kontopoulou, Konstantina; Nakas, Christos Theodore; Ainatzoglou, Alexandra; Ifantidou, Athina; Ntotsi, Paschalina; Katsioulis, Christos; Papazisis, Georgios
